A detailed history of E Fund Management Co., Ltd. transactions in Natera, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 8,587 shares of NTRA stock, worth $1.44 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
8,587
Previous 9,979 13.95%
Holding current value
$1.44 Million
Previous $1.08 Million 1.02%
% of portfolio
0.06%
Previous 0.06%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$97.75 - $129.67 $136,068 - $180,500
-1,392 Reduced 13.95%
8,587 $1.09 Million
Q2 2024

Aug 12, 2024

BUY
$85.28 - $112.6 $436,036 - $575,723
5,113 Added 105.08%
9,979 $1.08 Million
Q1 2024

May 13, 2024

SELL
$59.21 - $92.9 $200,958 - $315,302
-3,394 Reduced 41.09%
4,866 $445,000
Q4 2023

Feb 06, 2024

SELL
$37.55 - $62.64 $6,646 - $11,087
-177 Reduced 2.1%
8,260 $517,000
Q3 2023

Nov 13, 2023

SELL
$43.4 - $62.52 $34,503 - $49,703
-795 Reduced 8.61%
8,437 $373,000
Q2 2023

Aug 11, 2023

BUY
$47.08 - $55.16 $98,726 - $115,670
2,097 Added 29.39%
9,232 $449,000
Q1 2023

May 11, 2023

SELL
$36.57 - $58.29 $144,378 - $230,128
-3,948 Reduced 35.62%
7,135 $396,000
Q4 2022

Feb 14, 2023

BUY
$34.17 - $47.91 $71,107 - $99,700
2,081 Added 23.12%
11,083 $445,000
Q3 2022

Nov 14, 2022

SELL
$36.93 - $56.68 $140,370 - $215,440
-3,801 Reduced 29.69%
9,002 $394,000
Q2 2022

Aug 15, 2022

BUY
$28.13 - $44.54 $166,557 - $263,721
5,921 Added 86.04%
12,803 $454,000
Q1 2022

May 12, 2022

BUY
$30.32 - $91.33 $168,276 - $506,881
5,550 Added 416.67%
6,882 $280,000
Q1 2021

May 12, 2021

BUY
$91.47 - $124.36 $121,838 - $165,647
1,332 New
1,332 $135,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track E Fund Management Co., Ltd. Portfolio

Follow E Fund Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.